Farther Finance Advisors’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.1K Sell
2,524
-1,621
-39% -$10.2K ﹤0.01% 4412
2026
Q2
$23.5K Buy
4,145
+1,962
+90% +$9.59K ﹤0.01% 3856
2026
Q1
$9.85K Sell
2,183
-1,051
-32% -$5.86K ﹤0.01% 4124
2025
Q4
$29K Buy
3,234
+1,176
+57% +$7.29K ﹤0.01% 3181
2025
Q3
$7.62K Buy
2,058
+186
+10% +$507 ﹤0.01% 3566
2025
Q2
$3.65K Hold
1,872
– – ﹤0.01% 3489
2025
Q1
$3.28K Sell
1,872
-340
-15% -$774 ﹤0.01% 3211
2024
Q4
$5.88K Hold
2,212
– – ﹤0.01% 2598
2024
Q3
$5.07K Hold
2,212
– – ﹤0.01% 2637
2024
Q2
$6.99K Buy
+2,212
New +$6.75K ﹤0.01% 2238
2024
Q1
– Sell
-10
Closed -$15 – 3683
2023
Q4
$15 Buy
+10
New +$13 ﹤0.01% 3482

Other funds holding NUVB

Farther Finance Advisors's NUVB Position: Q3 2026 in Review

Farther Finance Advisors reduced its Nuvation Bio (NUVB) stake by 39% in Q3 2026, selling an estimated $10.2K and leaving 2,524 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4412.

Farther Finance Advisors first reported a position in NUVB in Q4 2023 and has held it in 11 quarters since. The position peaked at $29K in Q4 2025. 14 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Farther Finance Advisors held 2,524 shares of Nuvation Bio worth $14.1K as of Q3 2026.
  • Farther Finance Advisors sold 1,621 Nuvation Bio shares in Q3 2026, an estimated $10.2K.
  • Nuvation Bio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4412 holding.
  • Farther Finance Advisors first reported a position in Nuvation Bio in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Nuvation Bio position peaked at $29K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.